SAN DIEGO, June 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. announced today that management will deliver a corporate overview at the Pacific Growth Equities 2006 Life Sciences Growth Conference on Tuesday, June 13 at 9 a.m. Pacific Time. A link to the live audio webcast will be available via the "Investors" section of the Company's Web site at http://www.adventrx.com under "Events". A webcast replay of the corporate presentation will be available approximately 1 hour after the live webcast ends and will be accessible for 14 days.
The conference will be held June 12-14, 2006 at the InterContinental Mark Hopkins Hotel in San Francisco. For additional information about the conference, visit http://www.pacificgrowth.com/conference/index.html.
About ADVENTRX
ADVENTRX Pharmaceuticals is a biopharmaceutical research and development company focused on introducing treatments for cancer and infectious disease that surpass the performance and safety of existing drugs, by addressing significant problems such as drug metabolism, toxicity, bioavailability and resistance. More information can be found on the Company's Web site at www.adventrx.com.
Forward Looking Statement
This press release contains forward-looking statements, within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, regarding ADVENTRX. Such statements are made based on management's current expectations and beliefs. Actual results may vary from those currently anticipated based upon a number of factors, including uncertainties inherent in the drug development process, the timing and success of clinical trials, the validity of research results, and the receipt of necessary approvals from the FDA and other regulatory agencies. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements regarding ADVENTRX, see the section titled "Risk Factors" in ADVENTRX's last annual report on Form 10-K and its Quarterly Reports on Form 10-Q, as well as other reports that ADVENTRX files from time to time with the Securities and Exchange Commission. All forward-looking statements regarding ADVENTRX are qualified in their entirety by this cautionary statement. ADVENTRX undertakes no obligation to release publicly any revisions to forward-looking statements to reflect events or circumstances which occur after the date hereof.
ADVENTRX Pharmaceuticals, Inc.CONTACT: Andrea Lynn of ADVENTRX Pharmaceuticals, +1-858-552-0866
Company News On-Call: http://www.prnewswire.com/comp/920134.html/
